Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Han Li, Yu-Guang Wang, Zeng-Chun Ma, Gao Yun-Hang, Song Ling, Chen Teng-Fei, Zhang Guang-Ping & Yue Gao. (2021) A high-throughput cell-based gaussia luciferase reporter assay for measurement of CYP1A1, CYP2B6, and CYP3A4 induction. Xenobiotica 51:7, pages 752-763.
Read now
Read now
Imran Ullah, Yeongji Kim, Malgum Lim, Keon Bong Oh, Seongsoo Hwang, Yurianna Shin, Youngim Kim, Gi-Sun Im, Tai-Young Hur & Sun A Ock. (2017) In vitro 3-D culture demonstrates incompetence in improving maintenance ability of primary hepatocytes. Animal Cells and Systems 21:5, pages 332-340.
Read now
Read now
Varsha Dhamankar, Mahfoud Assem & Maureen D. Donovan. (2015) Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa. Inhalation Toxicology 27:14, pages 767-777.
Read now
Read now
María José Gómez-Lechón, José V Castell & María Teresa Donato. (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 837-854.
Read now
Read now
David D. Stranz, Shichang Miao, Scott Campbell, George Maydwell & Sean Ekins. (2008) Combined Computational Metabolite Prediction and Automated Structure-Based Analysis of Mass Spectrometric Data. Toxicology Mechanisms and Methods 18:2-3, pages 243-250.
Read now
Read now
Y. Uno, T. Kumano, G. Kito, R. Nagata, T. Kamataki & H. Fujino. (2007) CYP2C76-mediated species difference in drug metabolism: A comparison of pitavastatin metabolism between monkeys and humans. Xenobiotica 37:1, pages 30-43.
Read now
Read now
Marcella Martignoni, Geny M M Groothuis & Ruben de Kanter. (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opinion on Drug Metabolism & Toxicology 2:6, pages 875-894.
Read now
Read now
I. Gut, I. Ojima, R. Vaclavikova, P. Simek, S. Horsky, I. Linhart, P. Soucek, E. Kondrova, L. V. Kuznetsova & J. Chen. (2006) Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes. Xenobiotica 36:9, pages 772-792.
Read now
Read now
Sean Ekins, Sergey Andreyev, Andy Ryabov, Eugene Kirillov, Eugene A Rakhmatulin, Andrej Bugrim & Tatiana Nikolskaya. (2005) Computational prediction of human drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 1:2, pages 303-324.
Read now
Read now
Shufeng Zhou, Philip Kestell & James W. Paxton. (2002) PREDICTING PHARMACOKINETICS AND DRUG INTERACTIONS IN PATIENTS FROM IN VITRO AND IN VIVO MODELS: THE EXPERIENCE WITH 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), AN ANTI-CANCER DRUG ELIMINATED MAINLY BY CONJUGATION. Drug Metabolism Reviews 34:4, pages 751-790.
Read now
Read now
S. F. Zhou, M. D. Tingle, P. Kestell & J. W. Paxton. (2002) Species differences in the metabolism of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in vitro : implications for prediction of metabolic interactions in vivo. Xenobiotica 32:2, pages 87-107.
Read now
Read now
D. F. V. LEWIS, B. G. LAKE, M. DICKINS, P. J. EDDERSHAW, M. H. TARBIT & P. S. GOLDFARB. (1999) Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29:4, pages 361-393.
Read now
Read now
Y. NISHIBE, M. WAKABAYASHI, T. HARAUCHI & K. OHNO. (1998) Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver. Xenobiotica 28:6, pages 549-557.
Read now
Read now
S. Krusekopf, U. Kleeburg, A. G. Hildebrandt & K. Ruckpaul. (1997) Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica 27:1, pages 1-9.
Read now
Read now
A. P. BERESFORD*W. J. ELLIS, J. AYRTON, M. A. JOHNSON & D. F. V. LEWIS. (1997) Cytochrome P4501A(CYP1A) induction in rat and man by the benzodioxino derivative, fluparoxan. Xenobiotica 27:2, pages 159-173.
Read now
Read now
D. A. SMITH. (1997) Pharmacokinetics and pharmacodynamics in toxicology. Xenobiotica 27:5, pages 513-525.
Read now
Read now
D. F. V. LEWIS*B. G. LAKE. (1997) Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners. Xenobiotica 27:5, pages 443-478.
Read now
Read now
A. NAKAMURA*T. HIROTA, A. MORINO, T. SHIMADA & T. UEMATSU. (1997) N-oxidation of irsogladine by the CYP2C subfamily in the rat, dog, monkey and man. Xenobiotica 27:10, pages 995-1003.
Read now
Read now
K. Eguchi, Y. Nishibe, T. Baba & K. Ohno. (1996) Quantitation of cytochrome P450 enzymes (CYP1A1/2, 2B11, 2C21 and 3A12) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica 26:7, pages 755-763.
Read now
Read now
D. F. V. Lewis & B. G. Lake. (1996) Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 26:7, pages 723-753.
Read now
Read now
T. Niwa, H. Kaneko, Y. Naritomi, A. Togawa, T. Shiraga, K. Iwasaki, Z. Tozuka & T. Hata. (1995) Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey. Xenobiotica 25:10, pages 1041-1049.
Read now
Read now
H. Hanioka, M. Hamamura, K. Kakino, H. Ogata, H. Jinno, A. Takahashi, T. Nishimura & M. Ando. (1995) Dog liver microsomal P450 enzyme-mediated toluene biotransformation. Xenobiotica 25:11, pages 1207-1217.
Read now
Read now
Articles from other publishers (93)
Changyang Ma, Cunyu Liu, Mengjie Ren, Lili Cui, Xuefeng Xi & Wenyi Kang. (2023) Inhibitory effect of quercetin-3-O-α-rhamnoside, p-coumaric acid, phloridzin and 4-O-β-glucopyranosyl-cis-coumaric acid on rats liver microsomes cytochrome P450 enzyme activities. Food and Chemical Toxicology 172, pages 113583.
Crossref
Crossref
Zsófia Fedor, Anna Szentkirályi-Tóth, Gábor Nagy, Zoltán Szimrók, Eszter Varga, Anna Pászti, Zoltán Pászti, Ákos Jerzsele, Oliver Pilgram, Torsten Steinmetzer, Gábor Mátis, Zsuzsanna Neogrády & Erzsébet Pászti-Gere. (2022) Interspecies Comparisons of the Effects of Potential Antiviral 3-Amidinophenylalanine Derivatives on Cytochrome P450 1A2 Isoenzyme. Veterinary Sciences 9:4, pages 156.
Crossref
Crossref
Frank Bringezu & Stephanie Simon. (2022) Salmonella typhimurium TA100 and TA1535 and E. coli WP2 uvrA are highly sensitive to detect the mutagenicity of short Alkyl-N-Nitrosamines in the Bacterial Reverse Mutation Test. Toxicology Reports 9, pages 250-255.
Crossref
Crossref
František Bárta, Alena Dedíková, Michaela Bebová, Šárka Dušková, Jaroslav Mráz, Heinz H. Schmeiser, Volker M. Arlt, Petr Hodek & Marie Stiborová. (2021) Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats. International Journal of Molecular Sciences 22:19, pages 10479.
Crossref
Crossref
Daniela Schneider, Dirk Bier, Marcus Holschbach, Andreas Bauer & Bernd Neumaier. (2021) Species Differences in Microsomal Metabolism of Xanthine-Derived A1 Adenosine Receptor Ligands. Pharmaceuticals 14:3, pages 277.
Crossref
Crossref
Han Luo, Yuan Xu, Dongyi Sun, Yi Cheng, Zhenliang Sun, Jing Gao, Yuanjin Zhang & Xin Wang. (2020) Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays. Regulatory Toxicology and Pharmacology 113, pages 104637.
Crossref
Crossref
Mengjun Shi, Yiping Cui, Cunyu Liu, Changqin Li, Zhenhua Liu & Wen-yi Kang. (2020) CYPs-mediated drug-drug interactions on psoralidin, isobavachalcone, neobavaisoflavone and daidzein in rats liver microsomes. Food and Chemical Toxicology 136, pages 111027.
Crossref
Crossref
Radek Indra, Petr Pompach, Katarína Vavrová, Kateřina Jáklová, Zbyněk Heger, Vojtěch Adam, Tomáš Eckschlager, Kateřina Kopečková, Volker Manfred Arlt & Marie Stiborová. (2020) Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems. Environmental Toxicology and Pharmacology 74, pages 103310.
Crossref
Crossref
Hannah Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin & Mike-Andrew Westhoff. (2019) Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 7:3, pages 69.
Crossref
Crossref
Ludivine Wathier, Thomas Venet, Elodie Bonfanti, Hervé Nunge, Frédéric Cosnier, Cécile Parietti-Winkler, Pierre Campo & Benoît Pouyatos. (2019) Measuring the middle-ear reflex: A quantitative method to assess effects of industrial solvents on central auditory pathways. NeuroToxicology 74, pages 58-66.
Crossref
Crossref
Qian Li, Minghui Sun, Genyun Li, Lihui Qiu, Zi Huang, Jingyi Gong, Jiangeng Huang, Gao Li & Luqin Si. (2019) The sub-chronic impact of mPEG2k-PCLx polymeric nanocarriers on cytochrome P450 enzymes after intravenous administration in rats. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 101-113.
Crossref
Crossref
Radek Indra, Petr Pompach, Václav Martínek, Paulína Takácsová, Katarína Vavrová, Zbyněk Heger, Vojtěch Adam, Tomáš Eckschlager, Kateřina Kopečková, Volker Manfred Arlt & Marie Stiborová. (2019) Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation. International Journal of Molecular Sciences 20:14, pages 3392.
Crossref
Crossref
Jun Chul Park, Deok-Seo Yoon, Eunjin Byeon, Jung Soo Seo, Un-Ki Hwang, Jeonghoon Han & Jae-Seong Lee. (2018) Adverse effects of two pharmaceuticals acetaminophen and oxytetracycline on life cycle parameters, oxidative stress, and defensome system in the marine rotifer Brachionus rotundiformis. Aquatic Toxicology 204, pages 70-79.
Crossref
Crossref
Yuan Wei, Li Yang, Xiaoyan Zhang, Danjuan Sui, Changsuo Wang, Kai Wang, Mangting Shan, Dayong Guo & Hongyu Wang. (2018) Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method. Drug Metabolism and Disposition 46:5, pages 525-531.
Crossref
Crossref
Marie Stiborová, Helena Dračínská, Lucie Bořek-Dohalská, Zuzana Klusoňová, Jana Holecová, Markéta Martínková, Heinz H. Schmeiser & Volker M. Arlt. (2018) Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats. Toxicology 400-401, pages 48-56.
Crossref
Crossref
Adel Alkhedaide, Mohamed Mohamed Soliman & Zein Shaban Ibrahim. (2016) Carbonated soft drinks alter hepatic cytochrome P450 isoform expression in Wistar rats. Biomedical Reports 5:5, pages 607-612.
Crossref
Crossref
Helena Dračínská, František Bárta, Kateřina Levová, Alena Hudecová, Michaela Moserová, Heinz H. Schmeiser, Klaus Kopka, Eva Frei, Volker M. Arlt & Marie Stiborová. (2016) Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo. Toxicology 344-346, pages 7-18.
Crossref
Crossref
Bagavathy Shanmugam Karthikeyan, Mohammad Abdulkader Akbarsha & Subbiah Parthasarathy. (2016) Network analysis and cross species comparison of protein–protein interaction networks of human, mouse and rat cytochrome P450 proteins that degrade xenobiotics. Molecular BioSystems 12:7, pages 2119-2134.
Crossref
Crossref
Marie Stiborová, František Bárta, Kateřina Levová, Petr Hodek, Heinz Schmeiser, Volker Arlt & Václav Martínek. (2015) A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches. International Journal of Molecular Sciences 16:11, pages 27561-27575.
Crossref
Crossref
Marie Stiborová, František Bárta, Kateřina Levová, Petr Hodek, Eva Frei, Volker M. Arlt & Heinz H. Schmeiser. (2014) The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats. Archives of Toxicology 89:11, pages 2141-2158.
Crossref
Crossref
Andrea Babelova, Birgitta C. Burckhardt, Gabriela Salinas-Riester, Claudia Pommerenke, Gerhard Burckhardt & Maja Henjakovic. (2015) Next generation sequencing of sex-specific genes in the livers of obese ZSF1 rats. Genomics 106:4, pages 204-213.
Crossref
Crossref
Chunming Lyu, Wenbin Zhou, Yufeng Zhang, Shen Zhang, Fang Kou, Hai Wei, Ning Zhang & Zhong Zuo. (2015)
Identification and characterization of
in vitro
and
in vivo
metabolites of steroidal alkaloid veratramine
. Biopharmaceutics & Drug Disposition 36:5, pages 308-324.
Crossref
Crossref
Wei Guo, Xiaowei Shi, Wei Wang, Weili Zhang & Junxia Li. (2014) Identification of the rat liver cytochrome P450 enzymes involved in the metabolism of the calcium channel blocker dipfluzine hydrochloride. Environmental Toxicology and Pharmacology 38:3, pages 901-912.
Crossref
Crossref
Marie Stiborová, Kateřina Levová, František Bárta, Miroslav Šulc, Eva Frei, Volker M. Arlt & Heinz H. Schmeiser. (2014) The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats. Mutagenesis 29:3, pages 189-200.
Crossref
Crossref
Shinya Uchida, Shimako Tanaka & Noriyuki Namiki. (2014)
Simultaneous and comprehensive
in vivo
analysis of cytochrome P450 activity by using a cocktail approach in rats
. Biopharmaceutics & Drug Disposition 35:4, pages 228-236.
Crossref
Crossref
T. K. Motawi, Z. A. Teleb, N. A. El-Boghdady & S. A. Ibrahim. (2013) Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study. Journal of Physiology and Biochemistry 70:1, pages 225-237.
Crossref
Crossref
Jacek Wójcikowski, Anna Haduch & Władysława Anna Daniel. (2013) Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver. Pharmacological Reports 65:5, pages 1247-1255.
Crossref
Crossref
Shayne Cox GadEugenia Kraynov & Martin E. Dowty. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Jacek Wójcikowski, Anna Haduch & Władysława A. Daniel. (2012) Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver. Pharmacological Reports 64:6, pages 1411-1418.
Crossref
Crossref
Alexander V. LyubimovJoshua G. DeKeyser & Magang Shou. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
38
.
Thomas M. Polasek, Matthew P. Doogue & John O. Miners. (2011)
Metabolic activation of clopidogrel:
in vitro
data provide conflicting evidence for the contributions of CYP2C19 and PON1
. Therapeutic Advances in Drug Safety 2:6, pages 253-261.
Crossref
Crossref
Anna Haduch, Jacek Wójcikowski & Władysława A. Daniel. (2011) Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver. Pharmacological Reports 63:6, pages 1491-1499.
Crossref
Crossref
Tomasz Sozański, Jan Magdalan, Małgorzata Trocha, Antoni Szumny, Anna Merwid-Ląd, Wojciech Słupski, Marta Karaźniewicz-Łada, Grzegorz Kiełbowicz, Dorota Ksiądzyna & Adam Szeląg. (2011) Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats. Pharmacological Reports 63:5, pages 1258-1263.
Crossref
Crossref
Kateřina Levová, Michaela Moserová, Věra Kotrbová, Miroslav Šulc, Colin J. Henderson, C. Roland Wolf, David H. Phillips, Eva Frei, Heinz H. Schmeiser, Jaroslav Mareš, Volker M. Arlt & Marie Stiborová. (2011) Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model. Toxicological Sciences 121:1, pages 43-56.
Crossref
Crossref
Kaori Matsumoto, Eiichi Nemoto, Tetsuya Hasegawa, Masayuki Akimoto & Kenji Sugibayashi. (2011) In Vitro Characterization of the Cytochrome P450 Isoforms Involved in the Metabolism of 6-Methoxy-2-napthylacetic Acid, an Active Metabolite of the Prodrug Nabumetone. Biological and Pharmaceutical Bulletin 34:5, pages 734-739.
Crossref
Crossref
Mobashar Ahmad, Paul J Nicholls, H John Smith & Masoud Ahmadi. (2000) Effect of P450 Isozyme-selective Inhibitors on In-vitro Metabolism of Retinoic Acid by Rat Hepatic Microsomes. Journal of Pharmacy and Pharmacology 52:3, pages 311-314.
Crossref
Crossref
Mei-Tsz Su, Chien-Hsiun Chen, Po-Hsiu Kuo, Chao-Chin Hsu, I-Wen Lee, Hisan-An Pan, Ying-Ting Chen & Pao-Lin Kuo. (2010) Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertility and Sterility 93:1, pages 141-149.
Crossref
Crossref
Siyi Zhang, Mingyao Wang, Peter W. Villalta, Bruce R. Lindgren, Yanbin Lao & Stephen S. Hecht. (2009)
Quantitation of Pyridyloxobutyl DNA Adducts in Nasal and Oral Mucosa of Rats Treated Chronically with Enantiomers of
N
′-Nitrosonornicotine
. Chemical Research in Toxicology 22:5, pages 949-956.
Crossref
Crossref
Xia Chen, Chang-Kai Sun, Guo-Zhu Han, Jin-Yong Peng, Ying Li, Yan-Xia Liu, Yuan-Yuan Lv, Ke-Xin Liu, Qin Zhou & Hui-Jun Sun. (2009) Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significanly correlated with cytochrome P450 suppression. World Journal of Gastroenterology 15:15, pages 1829.
Crossref
Crossref
Igor Semak, Elena Korik, Maria Antonova, Jacobo Wortsman & Andrzej Slominski. (2008) Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. Journal of Pineal Research 45:4, pages 515-523.
Crossref
Crossref
Suma Krishnan & Scott Moncrief. (2007) An Evaluation of the Cytochrome P450 Inhibition Potential of Lisdexamfetamine in Human Liver Microsomes. Drug Metabolism and Disposition 35:1, pages 180-184.
Crossref
Crossref
Larry J. Jolivette & Sean Ekins. 2007.
131
176
.
M. Dostalek, J. Pistovcakova, J. Jurica, J. Tomandl, I. Linhart, A. Sulcová & E. Hadasova. (2005) Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver. Life Sciences 78:3, pages 239-244.
Crossref
Crossref
M. Dostalek, E. Hadasova, M. Hanesova, J. Pistovcakova, A. Sulcova, J. Jurica, J. Tomandl & I. Linhart. (2005) Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats. European Journal of Drug Metabolism and Pharmacokinetics 30:3, pages 195-201.
Crossref
Crossref
Matthew A. Cerny & Robert P. Hanzlik. (2005) Cyclopropylamine inactivation of cytochromes P450: Role of metabolic intermediate complexes. Archives of Biochemistry and Biophysics 436:2, pages 265-275.
Crossref
Crossref
Guobin Sun, Sheau-Fung Thai, Douglas B. Tully, Guy R. Lambert, Amber K. Goetz, Douglas C. Wolf, David J. Dix & Stephen Nesnow. (2005) Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicology Letters 155:2, pages 277-287.
Crossref
Crossref
Denis Projean, Sophie Dautrey, Huy Khan Vu, Thierry Groblewski, Jean-Louis Brazier & Julie Ducharme. (2005) Selective Downregulation of Hepatic Cytochrome P450 Expression and Activity in a Rat Model of Inflammatory Pain. Pharmaceutical Research 22:1, pages 62-70.
Crossref
Crossref
Gary Ginsberg, William SlikkerJrJr, James Bruckner & Babasaheb Sonawane. (2004) Incorporating children's toxicokinetics into a risk framework.. Environmental Health Perspectives 112:2, pages 272-283.
Crossref
Crossref
Marie Stiborová, Andrea Breuer, Dagmar Aimová, Martina Stiborová‐Rupertová, Manfred Wiessler & Eva Frei. (2003)
DNA adduct formation by the anticancer drug ellipticine in rats determined by
32
P postlabeling
. International Journal of Cancer 107:6, pages 885-890.
Crossref
Crossref
Qingyu Zhou & Eli Chan. (2003) Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. European Journal of Pharmaceutical Sciences 20:4-5, pages 439-449.
Crossref
Crossref
Kaoru Kobayashi, Kikuko Urashima, Noriaki Shimada & Kan Chiba. (2003) SELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RAT. Drug Metabolism and Disposition 31:7, pages 833-836.
Crossref
Crossref
María José Gómez-Lechón, Teresa Donato, Xavier Ponsoda & José V. Castell. (2003)
Human Hepatic Cell Cultures:
In Vitro
and
In Vivo
Drug Metabolism
. Alternatives to Laboratory Animals 31:3, pages 257-265.
Crossref
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
Shufeng Zhou, Philip Kestell, Bruce C Baguley & James W Paxton. (2003) Preclinical factors influencing the relative contributions of Phase I and II enzymes to the metabolism of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid. Biochemical Pharmacology 65:1, pages 109-120.
Crossref
Crossref
Roland N. Dickerson & Scott L. Charland. (2012) The Effect of Sepsis During Parenteral Nutrition on Hepatic Microsomal Function in Rats. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22:9, pages 1084-1090.
Crossref
Crossref
J.C. Huber, C. Schneeberger & C.B. Tempfer. (2002) Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 42:1, pages 1-12.
Crossref
Crossref
R. Zuber, Eva Anzenbacherová & P. Anzenbacher. (2007) Cytochromes P450 and experimental models of drug metabolism. Journal of Cellular and Molecular Medicine 6:2, pages 189-198.
Crossref
Crossref
J.C. Huber, C. Schneeberger & C.B. Tempfer. (2002) Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 41, pages 55-64.
Crossref
Crossref
Hideyuki Yamada, Noriko Gohyama, Shin-ichiro Honda, Takayuki Hara, Nobuhiro Harada & Kazuta Oguri. (2002) Estrogen-Dependent Regulation of the Expression of Hepatic Cyp2b and 3a Isoforms: Assessment Using Aromatase-Deficient Mice. Toxicology and Applied Pharmacology 180:1, pages 1-10.
Crossref
Crossref
Kaoru Kobayashi, Kikuko Urashima, Noriaki Shimada & Kan Chiba. (2002) Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology 63:5, pages 889-896.
Crossref
Crossref
Alexis B. Ulrich, Jens Standop, Bruno M. Schmied, Matthias B. Schneider, Terence A. Lawson & Parviz M. Pour. (2016) Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas. Toxicologic Pathology 30:2, pages 247-253.
Crossref
Crossref
Takashi Matsubara. (2002) Safety Evaluation and Drug Development based on Biological Fate of Drugs —Efforts Made to Overcome Drug Interaction in Drug Development—. Drug Metabolism and Pharmacokinetics 17:5, pages 379-394.
Crossref
Crossref
B C EkeM İşcan. (2016) Effects of cigarette smoke with different tar contents on hepatic and pulmonary xenobiotic metabolizing enzymes in rats. Human & Experimental Toxicology 21:1, pages 17-23.
Crossref
Crossref
. 2002. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists
121
168
.
I. Sekine & N. Saijo. (2001) Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Annals of Oncology 12:11, pages 1515-1525.
Crossref
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
K Walton, J.L Dorne & A.G Renwick. (2001) Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food and Chemical Toxicology 39:7, pages 667-680.
Crossref
Crossref
Genevieve Ubeaud, Claus-Ditter Schiller, Fabrice Hurbin, Daniel Jaeck & Philippe Coassolo. (2001) Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers. European Journal of Drug Metabolism and Pharmacokinetics 26:1-2, pages 37-45.
Crossref
Crossref
Michael D. Coleman, Daniel L. Rathbone, Rajinda Chima, Peter A. Lambert & David C. Billington. (2001) Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology 9:3, pages 99-102.
Crossref
Crossref
Vessela Nedelcheva Kristensen & Anne Lise Børresen-Dale. (2000) Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutation Research/Reviews in Mutation Research 462:2-3, pages 323-333.
Crossref
Crossref
Maura Spotti, Roel F.M Maas, Cornelia M de Nijs & Johanna Fink-Gremmels. (2000) Effect of fumonisin B1 on rat hepatic P450 system. Environmental Toxicology and Pharmacology 8:3, pages 197-204.
Crossref
Crossref
Michael D Coleman, Daniel L Rathbone, Catriona R Endersby, Melanie C Hovey, Katy J Tims, Peter A Lambert & David C Billington. (2000) Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II. Environmental Toxicology and Pharmacology 8:3, pages 167-172.
Crossref
Crossref
Kamil Hrubý, Eva Anzenbacherová, Pavel Anzenbacher & Milan Nobilis. (2000) Biotransformation of Benfluron by Rat Hepatic Cytochrome P450. Identification of Individual CYP-Enzymes Involved in Biotransformation of Benfluron, Prospective Antineoplastic Based on Benzo[c]fluorene. Collection of Czechoslovak Chemical Communications 65:8, pages 1374-1386.
Crossref
Crossref
M.Teresa Donato, José V Castell & M.José Gómez-Lechón. (1999) Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. Journal of Hepatology 31:3, pages 542-549.
Crossref
Crossref
G. Ubeaud, J. Hagenbach, S. Vandenschrieck, L. Jung & J.C. Koffel. (1999) In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin. Life Sciences 65:13, pages 1403-1412.
Crossref
Crossref
Y Matsumura, M Yokota, H Yoshioka, S Shibata, S Ida & Y Takiguchi. (2016) Acute Effects of Griseofulvin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats. Journal of International Medical Research 27:4, pages 167-175.
Crossref
Crossref
G. Morel, B. Cossec, A.M. Lambert & S. Binet. (1999) Evaluation of rat hepatic 2E1 activity in function of age, sex and inducers: choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds. Toxicology Letters 106:2-3, pages 171-180.
Crossref
Crossref
Michael D. Coleman, Daniel L. Rathbone, Lee Abberley, Peter A. Lambert & David C. Billington. (1999) Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds. Environmental Toxicology and Pharmacology 7:1, pages 59-65.
Crossref
Crossref
Julia A Hasler, Ronald Estabrook, Michael Murray, Irina Pikuleva, Michael Waterman, Jorge Capdevila, Vijakumar Holla, Christian Helvig, John R Falck, Geoffrey Farrell, Laurence S Kaminsky, Simon D Spivack, Eric Boitier & Philippe Beaune. (1999) Human cytochromes P450. Molecular Aspects of Medicine 20:1-2, pages 1-137.
Crossref
Crossref
M. Íscan, T. Çoban, D. Bülbül, B. C. Eke, S. Aygörmez & U. Berberoglu. (1998) Xenobiotic metabolizing and antioxidant enzymes in normal and neoplastic human breast tissue. European Journal of Drug Metabolism and Pharmacokinetics 23:4, pages 497-500.
Crossref
Crossref
M Amichot, A Brun, A Cuany, G De Souza, T Le Mouél, J.M Bride, M Babault, J.P Salaün, R Rahmani & J.B Bergé. (1998) Induction of cytochrome P450 activities in Drosophila melanogaster strains susceptible or resistant to insecticides. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 121:1-3, pages 311-319.
Crossref
Crossref
S. Barceló, K. Macé, A.M.A. Pfeifer & J.K. Chipman. (1998) Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 402:1-2, pages 111-120.
Crossref
Crossref
Benay Can-Eke, M. Orhan Puskullu, Erdem Buyukbingol & Mumtaz Iscan. (1998) A study on the antioxidant capacities of some benzimidazoles in rat tissues. Chemico-Biological Interactions 113:1, pages 65-77.
Crossref
Crossref
Victoria A. Eagling, John F. Tjia & David J. Back. (2002) Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology 45:2, pages 107-114.
Crossref
Crossref
Benay C Eke, Tülay Çoban, Nevın Vural & Mümtaz İşcan. (1998) Gender dependent effects of cigarette smoke on hepatic and pulmonary xenobiotic metabolizing enzymes in rats. Environmental Toxicology and Pharmacology 5:1, pages 29-34.
Crossref
Crossref
Robert J. Riley & D. Howbrook. (1997) In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. Journal of Pharmacological and Toxicological Methods 38:4, pages 189-193.
Crossref
Crossref
D J Kempf, K C Marsh, G Kumar, A D Rodrigues, J F Denissen, E McDonald, M J Kukulka, A Hsu, G R Granneman, P A Baroldi, E Sun, D Pizzuti, J J Plattner, D W Norbeck & J M Leonard. (1997) Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrobial Agents and Chemotherapy 41:3, pages 654-660.
Crossref
Crossref
Stephan K. Grant, Barbara G. Green, Regina Wang, Stephen G. Pacholok & John W. Kozarich. (1997) Characterization of Inducible Nitric-oxide Synthase by Cytochrome P-450 Substrates and Inhibitors. Journal of Biological Chemistry 272:2, pages 977-983.
Crossref
Crossref
Thomas N. Thompson. 1997.
205
229
.
P. Olinga, D.K.F. Meijer, M.J.H. Slooff & G.M.M. Groothuis. (1997) Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicology in Vitro 12:1, pages 77-100.
Crossref
Crossref
G. Van't Klooster & K. Lavrijsen. 1997. Proceedings XIVth International Symposium on Medicinal Chemistry. Proceedings XIVth International Symposium on Medicinal Chemistry
219
230
.
Benay C. Eke, Nevin Vural & Mümtaz ǎİşcan. (1996) Combined effects of ethanol and cigarette smoke on hepatic and pulmonary xenobiotic metabolizing enzymes in rats. Chemico-Biological Interactions 102:3, pages 155-167.
Crossref
Crossref
Susumu Imaoka, Takao Yamada, Toyoko Hiroi, Koji Hayashi, Toshiyuki Sakaki, Yoshiyasu Yabusaki & Yoshihiko Funae. (1996) Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Biochemical Pharmacology 51:8, pages 1041-1050.
Crossref
Crossref